Therapeutic Asset Ratings
283 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Chimeric Antigen Receptor Modified T Cells Infusion
Autologous Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cladribine
Newly Diagnosed
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cyclophosphamide
Azacytidine
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cyclophosphamide
Conditioning Therapy
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cyclophosphamide
Safety Issues
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cyclophosphamide
SHR2554
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
CYCLOSPORIN A
Azacytidine
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
CYCLOSPORIN A
Conditioning Therapy
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
CYCLOSPORIN A
SHR2554
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cytosin-Arabinosid
Azacytidine
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cytosin-Arabinosid
Conditioning Therapy
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cytosin-Arabinosid
Consolidation Therapy
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cytosin-Arabinosid
High Risk
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cytosin-Arabinosid
SHR2554
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Cytosin-Arabinosid
Venentoclax
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
DARATUMUMAB
Daratumumab
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
DEXAMETHASONE
Daratumumab
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Docetaxel
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
ETOPOSIDE
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Fludarabine
Autologous Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Humanized Cd7 Car-T Cells
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
HUMAN PERIPHERAL BLOOD LEUKOCYTES
Autologous Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Safety Issues
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Inno-206
Safety Issues
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Showing 126 to 150 of 283 assets
Previous
Page 6 of 12
Next